Literature DB >> 20604618

Self-paced timing detects and tracks change in prodromal Huntington disease.

Kelly C Rowe1, Jane S Paulsen, Douglas R Langbehn, Kevin Duff, Leigh J Beglinger, Chiachi Wang, Justin J F O'Rourke, Julie C Stout, David J Moser.   

Abstract

OBJECTIVE: This study compares self-paced timing performance (cross-sectionally and longitudinally) between participants with prodromal Huntington's disease (pr-HD) and a comparison group of gene non-expanded participants from affected families (NC).
METHOD: Participants (747 pr-HD: 188 NC) listened to tones presented at 550-ms intervals, matched that pace by tapping response keys and continued the rhythm (self-paced) after the tone had stopped. Standardized cross-sectional and longitudinal linear models examined the relationships between self-paced timing precision and estimated proximity to diagnosis, and other demographic factors.
RESULTS: Pr-HD participants showed significantly less timing precision than NC. Comparison of pr-HD and NC participants showed a significant performance difference on two task administration conditions (dominant hand: p < .0001; alternating thumbs: p < .0001). Additionally, estimated proximity to diagnosis was related to timing precision in both conditions, (dominant hand: t = -11.14, df = 920, p < .0001; alternating thumbs: t = -11.32, df = 918, p < .0001). Longitudinal modeling showed that pr-HD participants worsen more quickly at the task than the NC group, and rate of decline increases with estimated proximity to diagnosis in both conditions (dominant hand: t = -2.85, df = 417, p = .0045; alternating thumbs: t = -3.56, df = 445, p = .0004). Effect sizes based on adjusted mean annual change ranged from -0.34 to 0.25 in the longitudinal model.
CONCLUSIONS: The self-paced timing paradigm has potential for use as a screening tool and outcome measure in pr-HD clinical trials to gauge therapeutically mediated improvement or maintenance of function.

Entities:  

Mesh:

Year:  2010        PMID: 20604618      PMCID: PMC2900808          DOI: 10.1037/a0018905

Source DB:  PubMed          Journal:  Neuropsychology        ISSN: 0894-4105            Impact factor:   3.295


  26 in total

Review 1.  How do we tell time?

Authors:  Dean V Buonomano; Uma R Karmarkar
Journal:  Neuroscientist       Date:  2002-02       Impact factor: 7.519

2.  The distribution of structural neuropathology in pre-clinical Huntington's disease.

Authors:  M J Thieben; A J Duggins; C D Good; L Gomes; N Mahant; F Richards; E McCusker; R S J Frackowiak
Journal:  Brain       Date:  2002-08       Impact factor: 13.501

3.  Functional neuroimaging correlates of finger-tapping task variations: an ALE meta-analysis.

Authors:  Suzanne T Witt; Angela R Laird; M Elizabeth Meyerand
Journal:  Neuroimage       Date:  2008-04-16       Impact factor: 6.556

4.  Dissociation of the lateral and medial cerebellum in movement timing and movement execution.

Authors:  R B Ivry; S W Keele; H C Diener
Journal:  Exp Brain Res       Date:  1988       Impact factor: 1.972

5.  Estimation of short temporal intervals in Alzheimer's disease.

Authors:  M C Carrasco; M J Guillem; R Redolat
Journal:  Exp Aging Res       Date:  2000 Apr-Jun       Impact factor: 1.645

6.  Neural basis for impaired time reproduction in Parkinson's disease: an fMRI study.

Authors:  Catherine L Elsinger; Stephen M Rao; Janice L Zimbelman; Norman C Reynolds; Karen A Blindauer; Raymond G Hoffmann
Journal:  J Int Neuropsychol Soc       Date:  2003-11       Impact factor: 2.892

7.  Hand tapping: a simple, reproducible, objective marker of motor dysfunction in Huntington's disease.

Authors:  A W Michell; A O G Goodman; A H D Silva; S E Lazic; A J Morton; R A Barker
Journal:  J Neurol       Date:  2008-05-13       Impact factor: 4.849

8.  Differential loss of striatal projection neurons in Huntington disease.

Authors:  A Reiner; R L Albin; K D Anderson; C J D'Amato; J B Penney; A B Young
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

9.  fMRI detection of early neural dysfunction in preclinical Huntington's disease.

Authors:  Janice L Zimbelman; Jane S Paulsen; Ania Mikos; Norman C Reynolds; Raymond G Hoffmann; Stephen M Rao
Journal:  J Int Neuropsychol Soc       Date:  2007-09       Impact factor: 2.892

10.  A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length.

Authors:  D R Langbehn; R R Brinkman; D Falush; J S Paulsen; M R Hayden
Journal:  Clin Genet       Date:  2004-04       Impact factor: 4.438

View more
  34 in total

1.  Time perception impairment in early-to-moderate stages of Huntington's disease is related to memory deficits.

Authors:  Stefania Righi; Luca Galli; Marco Paganini; Elisabetta Bertini; Maria Pia Viggiano; Silvia Piacentini
Journal:  Neurol Sci       Date:  2015-08-23       Impact factor: 3.307

2.  Variability in interval production is due to timing-dependent deficits in Huntington's disease.

Authors:  Ashwini K Rao; Karen S Marder; Jasim Uddin; Brian C Rakitin
Journal:  Mov Disord       Date:  2014-08-22       Impact factor: 10.338

3.  Regional atrophy associated with cognitive and motor function in prodromal Huntington disease.

Authors:  Elizabeth H Aylward; Deborah L Harrington; James A Mills; Peggy C Nopoulos; Christopher A Ross; Jeffrey D Long; Dawei Liu; Holly K Westervelt; Jane S Paulsen
Journal:  J Huntingtons Dis       Date:  2013

4.  Movement sequencing in Huntington disease.

Authors:  Nellie Georgiou-Karistianis; Jeffrey D Long; Spencer G Lourens; Julie C Stout; James A Mills; Jane S Paulsen
Journal:  World J Biol Psychiatry       Date:  2014-03-28       Impact factor: 4.132

5.  The structural correlates of functional deficits in early huntington's disease.

Authors:  Christine Delmaire; Eve M Dumas; Michael A Sharman; Simon J A van den Bogaard; Romain Valabregue; Céline Jauffret; Damian Justo; Ralf Reilmann; Julie C Stout; David Craufurd; Sarah J Tabrizi; Raymund A C Roos; Alexandra Durr; Stéphane Lehéricy
Journal:  Hum Brain Mapp       Date:  2012-03-22       Impact factor: 5.038

Review 6.  Cognitive impairment in Huntington disease: diagnosis and treatment.

Authors:  Jane S Paulsen
Journal:  Curr Neurol Neurosci Rep       Date:  2011-10       Impact factor: 5.081

7.  Indexing disease progression at study entry with individuals at-risk for Huntington disease.

Authors:  Ying Zhang; Jeffrey D Long; James A Mills; John H Warner; Wenjing Lu; Jane S Paulsen
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2011-08-19       Impact factor: 3.568

Review 8.  Prospects for neuroprotective therapies in prodromal Huntington's disease.

Authors:  Abhishek Chandra; Ashu Johri; M Flint Beal
Journal:  Mov Disord       Date:  2014-02-26       Impact factor: 10.338

9.  Keep up the pace: declines in simple repetitive timing differentiate healthy aging from the earliest stages of Alzheimer's disease.

Authors:  Ashley S Bangert; David A Balota
Journal:  J Int Neuropsychol Soc       Date:  2012-08-29       Impact factor: 2.892

10.  Intra-individual Variability in Prodromal Huntington Disease and Its Relationship to Genetic Burden.

Authors:  Mandi Musso; Holly James Westervelt; Jeffrey D Long; Erin Morgan; Steven Paul Woods; Megan M Smith; Wenjing Lu; Jane S Paulsen
Journal:  J Int Neuropsychol Soc       Date:  2015-01       Impact factor: 2.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.